Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder

NCT01658150 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: isradipine

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]